Latent iron deficiency and iron deficiency anemia in pregnant women. Diagnostic and treatment algorithms
- Авторлар: Dikke G.B1, Stuklov N.I2
-
Мекемелер:
- Academy of Medical Education n.a. F.I. Inozemtsev
- Peoples' Friendship University of Russia
- Шығарылым: Том 28, № 6 (2021)
- Беттер: 19-24
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/313159
- DOI: https://doi.org/10.18565/pharmateca.2021.6.19-24
- ID: 313159
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
Background. Iron deficiency anemia (IDA) is a common disease among pregnant women in the Russian Federation, averaging 36%; in severe cases, it complicates the course and outcomes of pregnancy and childbirth for the mother and newborn, which determines the need for early diagnosis of iron deficiency (ID) and its correction. Results. It was noted that the most common cause of ID in pregnant women is an insufficient intake of iron from food or an already existing latent iron deficiency before pregnancy. The clinical and laboratory characteristics of IDA and latent iron deficiency (LID) are presented. The importance of the determination of serum ferritin (FS) level in the screening of LID is emphasized. Modern methods of diagnostics and treatment of LID and IDA during pregnancy are presented in the form of algorithms developed on the basis of the provisions of the Council of Experts (June, 2020). Conclusion. Currently, the screening of ID with the determination of SF level should become the standard of medical care for pregnant women. It is necessary to inform women of reproductive age planning a pregnancy about the adverse consequences of ID and its correction before pregnancy.
Негізгі сөздер
Толық мәтін
Авторлар туралы
G. Dikke
Academy of Medical Education n.a. F.I. Inozemtsev
Email: galadikke@yandex.ru
Dr. Sci. (Med.), Associate Professor, Professor of the Department of Obstetrics and Gynecology with a course of reproductive medicine
N. Stuklov
Peoples' Friendship University of Russia
Әдебиет тізімі
- Резолюция совета экспертов по железодефицитной анемии у женщин. Акушерство и гинекология: новости, мнения, обучение. 2020;8(4):28-36. doi: 10.24411/2303-9698-2020-14004.
- Kumari S., Garg N., Kumar A., et al. Maternal and severe anaemia in delivering women is associated with risk of preterm and low birth weight: A cross sectional study from Jharkhand, India. One Health. 2019;8:100098. doi: 10.1016/j.onehlt.2019.100098.
- Daru J., Zamora J., Fernandez-Felix B.M., et al. Risk of maternal mortality in women with severe anaemia during pregnancy and postpartum: a multilevel analysis. Lancet. Glob Health. 2018;6(5):e548-54. doi: 10.1016/S2214-109X(18)30078-0.
- Nikzad Z., Iravani M., Abedi P., et al. The relationship between iron deficiency anemia and sexual function and satisfaction among reproductive-aged Iranian women. PDS One. 2018;13(12):e0208485. doi: 10.1371/journal.pone.0208485.
- Rahman M.M., Abe S.K., Rahman M.S., et al. Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis. Am J. Cin Nutr. 2016;103(2):495-504. Doi: 10.3945/ ajcn.115.107896.
- Scott S.P., Chen-Edinboro L.P., Caulfield L.E., Murray-Kolb L.E. The impact of anemia on child mortality: an updated review. Nutrients. 2014;6(12):5915-32. doi: 10.3390/nu6125915.
- Bencaiova G., Breymann C. Mild anemia and pregnancy outcome in a Swiss collective. J. Pregnancy. 2014;2014:307535. doi: 10.1155/2014/307535.
- Haider B.A., Olofin I., Wang M., et al. Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2013;346:f3443. doi: 10.1136/bmj.f3443.
- Milman N. Prepartum anaemia: Prevention and treatment. Ann Hematol. 2008;87:949-59.
- Auerbach M., Abernathy J., Juul S., et al. Prevalence of iron deficiency in first trimester, nonanemic pregnant women. J. Matern Fetal Neonatal Med. 2021;34(6):1002-5. doi: 10.1080/14767058.2019.1619690.
- Стуклов Н.И., Митченкова А.А., Ковальчук М.С. Анемия беременных. Взгляд гематолога. Фарматека. 2019;26(6):90-6. Doi: 10.18565/ pharmateca.2019.6.90-96.
- WHO: Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. WHO/NHD/01.3. Geneva: WHO; 2001. 132 р.
- World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: World Health Organization; 2020. 82 р.
- Means R.T. Iron Deficiency and Iron Deficiency Anemia: Implications and Impact in Pregnancy, Fetal Development, and Early Childhood Parameters. Nutrients. 2020;12(2):447. Doi: 10.3390/ nu12020447.
- Friedrisch J.R., Friedrisch B.K. Prophylactic Iron Supplementation in Pregnancy: A Controversial Issue. Biochem Insights. 2017;10:1178626417737738. doi: 10.1177/1178626417737738.
- Peha-Rosas J.P., De-Regil L.M., Gomez Malave H., et al. Intermittent oral iron supplementation during pregnancy Cochrane Database Syst Rev. 2015;2015(10):CD009997. doi: 10.1002/14651858.CD009997.pub2.
- WHO Guideline: Daily iron supplementation in adult women and adolescent girls. Geneva: World Health Organization; 2016. 33 р.
- Стуклов Н.И., Альпидовский В.К., Огурцов П.П. Анемии. Клиника, диагностика и лечение. Учебное пособие для врачей. М., 2013. 264 с.
- Myers B., Myers O., Moore J. Comparative efficacy and safety of intravenous ferric carboxymaltose (Ferinject) and iron (III) hydroxide dextran (Cosmofer) in pregnancy. Obstet Med. 2012;5(3):105-7. doi: 10.1258/om.2012.110095.
- Wong L., Smith S., Gilstrop M., et al. Safety and efficacy of rapid (1,000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy. Am J. Hematol. 2016;91(6):590-93. doi: 10.1002/ajh.24361.
Қосымша файлдар
